Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib + Bicalutamide in Chemo-Naïve HRPC
NCT00430235Phase 2Completed
- Sponsor
- BC Cancer
- Start
- Mar 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in prostate cancer (PCa), sponsored by BC Cancer. Started Mar 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00430235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430235.